Arteriovenous Malformation Treatment Market Statistics, Global Overview and Forecast to 2023
Market Synopsis:
The
increasing support and rising investments for research & development
activities are likely to intensify the
competitive landscape of the arteriovenous malformation market in the
forthcoming years. Additionally, the need for better treatment facilities is
another major factor favoring the growth of the market. AVM is mostly
hereditary, although it can be developed in later life too, and the need for
its treatment has increased with the rising awareness about the disease.
Market
Research Future (MRFR)’s latest report projects that the global Arteriovenous
Malformation Treatment Market Share is set to expand at 6.1% CAGR
during the forecast period 2017 to 2023. The developments and
innovations introduced in the healthcare sector have
intensified the competition in the market. There are several types of
Arteriovenous Malformations (AVM), such as occult or cryptic AVM or cavernous
malformations, true arteriovenous
malformation, and others. The industry leaders endeavor to develop customized
and effective medical facilities for each
of these types which is likely to fuel demand in the market.
Competitive Dashboard:
·
Toshiba Medical Systems Corporation
·
Nihon Kohden Corporation
·
Electrical Geodesics Inc
·
Carestream Health
·
Fujifilm Holdings
·
Siemens Healthcare
·
Philips Healthcare
·
GE Healthcare
·
Shimadzu Corporation
·
Hologic
·
Masimo Corporation
Market Segmentation:
·
By type, the global arteriovenous
malformation market is segmented into true arteriovenous malformation, occult or
cryptic AVM or cavernous malformations, venous malformation, hemangioma, and
dural fistula.
·
By diagnosis, the arteriovenous
malformation market has been segmented
into physical examination, blood test,
brain scans, and others. The brain scan segment is further sub-segmented into
Computerized Tomography (CT) scan, Magnetic Resonance Imaging (MRI), Magnetic Resonance
Angiography (MRA), and Electroencephalography (EEG).
·
By treatment, the global arteriovenous
malformation market is segmented into
endovascular embolization, neurosurgery, and
others.
·
By end-user, the arteriovenous malformation
market has been segmented into hospitals
& clinics, research laboratories, and
others.
Regional Analysis:
By
region, the global arteriovenous malformation market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa.
Americas dominate the global market currently and is expected to exhibit
substantial growth in the forthcoming years. The growth can be ascribed to the
factors such as high health care spending, developed healthcare technology,
rising R&D activities, increasing patient pool, and presence of key players among others.
Europe
is the second largest market for arteriovenous malformation. The factors
responsible for favoring the expansion of the regional arteriovenous
malformation market are government support and the availability of funds for research & development activities.
Furthermore, the concentration of developed economies is likely to propel the growth of the arteriovenous malformation market
over the next couple of years.
Asia Pacific is projected to be the fastest
growing regional market owing to rapid developments in healthcare facilities.
Meanwhile, the Middle East & Africa is prognosticated to account for the
least share in the arteriovenous malformation market due to poor socio-economic condition prevailing in African regions.
Industry News:
In
March 2018, Canon Medical Systems, Japan, acquired Dutch medical equipment
manufacturer Fysicon B.V.
In
April 2018, private equity firm Veritas Capital acquired healthcare technology
unit of General Electric, the U.S.
Related Reports:
Needle Free Injection
Market Research Report – Forecast to 2023
https://www.marketresearchfuture.com/infographics/needle-free-injection-market
Menstrual Cup Market
Research Report- Forecast To 2023
Comments
Post a Comment